Using our previously described PSMA CRISPR knockout human prostate cancer C42B cell line (45), we treated C42B-CRISPR-PSMAscramble and C42B-CRISPR-PSMAknockout with 10μM FAM-C6-1298 for 30 min. Here, FOLH1 is linked to prostate cancer.